Insider Transactions in Q3 2019 at Mirum Pharmaceuticals, Inc. (MIRM)
Insider Transaction List (Q3 2019)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 10
2019
|
Lara Longpre CHIEF DEVELOPMENT OFFICER |
BUY
Open market or private purchase
|
Direct |
965
+0.91%
|
$9,650
$10.64 P/Share
|
|
Jul 22
2019
|
James E Flynn > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
332,000
+29.39%
|
$4,980,000
$15.0 P/Share
|
|
Jul 22
2019
|
James E Flynn > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
3,116,912
+50.0%
|
-
|
|
Jul 22
2019
|
Novo Holdings > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
575,000
+19.04%
|
$8,625,000
$15.0 P/Share
|
|
Jul 22
2019
|
Novo Holdings > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
1,870,147
+50.0%
|
-
|